Home › NDC Lookup › RxCUI directory › RxCUI 2668599

Entrectinib 50 MG Oral Pellet [Rozlytrek] — RxCUI 2668599

RxNorm drug concept · Semantic branded drug
RxCUI 2668599 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2668599
Official nameEntrectinib 50 MG Oral Pellet [Rozlytrek]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asRozlytrek 50 MG Oral Pellet
FDA products mapped3
Package NDCs mapped5
Reported Medicaid activity (SDUD)45 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Entrectinib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Rozlytrek treats certain cancers that have specific gene changes — either a ROS1 rearrangement in non-small cell lung cancer, or an NTRK gene fusion in other solid tumors. Before y...
  • What exactly does Rozlytrek treat, and how do I know if it's right for me?
  • You take Rozlytrek once a day by mouth. The good news is it can be taken with or without food — a big or fatty meal doesn't significantly change how much of the drug your body abso...
  • How do I take Rozlytrek, and does it matter if I take it with food?
📖 Read our full Entrectinib guide →

🕸️ Concept Web — How Entrectinib 50 MG Oral Pellet [Rozlytrek] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Entrectinib 50 MG Oral Pellet [Rozlytrek] RxCUI 2668599

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Entrectinib 2197862
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Rozlytrek 2197868
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Entrectinib Oral Pellet 2668594
    • Entrectinib Oral Product 2197864
    • Entrectinib Pellet Product 2668593
    • Entrectinib Oral Pellet [Rozlytrek] 2668598
    • Rozlytrek Oral Product 2197871
    • Rozlytrek Pellet Product 2668597
    • Oral Pellet 317691
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Entrectinib 50 MG Oral Pellet SCD · 2668595
  • Entrectinib 50 MG SCDC · 2668592
  • Entrectinib Oral Pellet SCDF · 2668594
  • Entrectinib Oral Product SCDG · 2197864
  • Entrectinib Pellet Product SCDG · 2668593

Brand-Name Concepts

  • Entrectinib 50 MG [Rozlytrek] SBDC · 2668596
  • Entrectinib Oral Pellet [Rozlytrek] SBDF · 2668598
  • Rozlytrek Oral Product SBDG · 2197871
  • Rozlytrek Pellet Product SBDG · 2668597
  • Rozlytrek BN · 2197868

📦 FDA Products & Package NDCs

3 products · 5 package NDCs
5 package NDCs map to RxCUI 2668599 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50242-0091-30 1 BOTTLE in 1 CARTON (50242-091-30) / 30 CAPSULE in 1 BOTTL... Rozlytrek Genentech, Inc. 2019-08-15
50242-0091-86 1 BOTTLE in 1 CARTON (50242-091-86) / 30 CAPSULE in 1 BOTTL... Rozlytrek Genentech, Inc. 2019-08-15
50242-0094-47 1 BOTTLE in 1 CARTON (50242-094-47) / 90 CAPSULE in 1 BOTTL... Rozlytrek Genentech, Inc. 2019-08-15
50242-0094-90 1 BOTTLE in 1 CARTON (50242-094-90) / 90 CAPSULE in 1 BOTTL... Rozlytrek Genentech, Inc. 2019-08-15
50242-0623-42 42 DOSE PACK in 1 CARTON (50242-623-42) / 20 PELLET in 1 DO... Rozlytrek Genentech, Inc. 2023-10-20
Observed labelers: Genentech, Inc. (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.